Sectinomycin in the treatment of gonorrhoea in females and males.
126 female patients with proven gonococcal infection were treated with 4 g. spectinomycin bihydrochloride given intramuscularly in a single does. In 120 cases followed up there were four possible treatment failures, giving a cure rate of 97-6 per cent. 99 male patients with acute gonococcal urethritis were treated with a single dose of 2, g. sectinomycin bihydrochloride. Of 88 cases followed up, there were three possible treatment failures, giving a cure rate of 96-6 per cent. Spectinomycin is an important addition to gonorrhoea therapy but should be reserved for penicillin sensitive patients and penicillin insensitive infections.
D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D006069:Gonorrhea / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D010403:Penicillin Resistance; D012008:Recurrence; D000198:Spectinomycin / Q000627:therapeutic use*; D014521:Urethra / Q000382:microbiology
D000198:Spectinomycin